← Open Payments lookup

MEREDITH XIMINES-MULLINGS: Open Payments

NPI 1972385102 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,039 in 25 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $905 · 2025 $1,039

Food & beverage: $1,039
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$243
E.R. Squibb & Sons, L.L.C.3$173
Janssen Pharmaceuticals, Inc2$171
Teva Pharmaceuticals USA, Inc.6$123
Otsuka America Pharmaceutical, Inc.1$111
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$50
ACADIA Pharmaceuticals Inc1$45
Otsuka Pharmaceutical Development & Commercialization, Inc.1$31
Axsome Therapeutics, Inc.1$29
Collegium Pharmaceutical, Inc.1$23

Products named: COBENFY, SPRAVATO, HETLIOZ, FANAPT, REXULTI, AUSTEDO XR, CAPLYTA, NUPLAZID.

Industry payments across FL — which companies pay providers there.